FPCI-AL for Dementia
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to improve the quality of staff-resident care interactions particularly among residents living with Alzheimer's disease or related dementias (ADRD ) by testing the Fostering Positive Care Interactions in Assisted Living (FPCI-AL) intervention. This study will be a critical first step in determining the sample size needed to test the efficacy of a practical approach to improving the quality of care interactions for assisted living residents living with ADRD, ultimately enhancing behavioral outcomes such as decreasing behavioral symptoms of distress, reducing resistiveness to care, and optimizing engagement in care tasks.
Are You a Good Fit for This Trial?
This trial is for people aged 55 or older who live in participating assisted living communities and have Alzheimer's disease or related dementias, shown by a low score on a mental status test.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Fostering Positive Care Interactions in Assisted Living (FPCI-AL)
Trial Overview
The study compares two approaches: an education-only program versus the FPCI-AL intervention, which aims to help staff improve their interactions with residents who have dementia. The goal is to see if these methods can reduce distress and improve care engagement.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The FPCI-AL is implemented using a research facilitator working with a community-based champion and stakeholder group to provide the following four-steps: (1) assessments of the environment and policy to facilitate positive interactions; (2) educating staff on fostering positive interactions; (3) establishing individualized positive care interaction approaches for residents and incorporating them into resident service plans; and (4) providing ongoing mentoring, motivating, and role modeling for staff to reinforce positive care interactions.
Communities randomized to education only will receive the same education as provided in FPCI-AL step two via an established PowerPoint. Delivery format will match community preferences (e.g., online or in-person) for pragmatic reasons and to facilitate the education process.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, Baltimore
Lead Sponsor
Alzheimer's Association
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.